Industry stakeholder meeting on Brexit and operation of centralised procedure for human and veterinary medicines
Date:
24/09/2018
Location:
European Medicines Agency, London, UK
The purpose of this meeting between the European Medicines Agency (EMA) and European Union trade associations is to update industry stakeholders responsible for human and veterinary medicines on EMA's Brexit preparedness activities.
-
List item
Agenda – Industry stakeholder meeting on Brexit and operation of centralised procedure for human and veterinary medicinal products (PDF/60.63 KB)
First published: 02/10/2018
EMA/642642/2018 -
List item
Report of Industry Stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal products (PDF/144.46 KB)
First published: 13/11/2018
EMA/694143/2018 -
List item
Presentation - Negotiations with the United Kingdom (Stefan Fuehring) (PDF/303.43 KB)
First published: 10/10/2018 -
List item
Presentation - Operational preparedness for Brexit and next phase of the Business continuity plan (BCP) (Noël Wathion) (PDF/131.31 KB)
First published: 10/10/2018 -
List item
Presentation - Update on European Medicines Agency Committees’ Operational Preparedness (Monica Dias) (PDF/124.47 KB)
First published: 10/10/2018 -
List item
Presentation - European Medicines Agency industry survey summary results (Alberto Jimenez,) (PDF/232.07 KB)
First published: 10/10/2018 -
List item
Presentation - Joint human medicines industry presentation (PDF/502.97 KB)
First published: 10/10/2018 -
List item
Presentation - Joint veterinary medicines industry presentation (PDF/97.72 KB)
First published: 10/10/2018